Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

Disease Characteristics and Treatment Effects

  • Primary Progressive Multiple Sclerosis (PPMS) is characterized by progressive neurological damage rather than relapses and remissions, with continuous accumulation of disability over time 1

Treatment Outcomes and Expectations

  • No cited facts are available for this section 1

REFERENCES